Novo Nordisk

Newsletter covering Novo Nordisk

News & Trending TopicsTheon InternationalPandoraThe Octopus toolboxLonza Group AGIntroductionMiscellaneousThe Octopus PortfolioColoplast A/SSectors in briefInvestment pillsSchott Pharma AGJeronimo MartinsEarnings ReviewNovo Nordisk
Novo NordiskNovo Nordisk
Novo Nordisk - H1 2025 Earnings Review

Novo Nordisk - H1 2025 Earnings Review

Lars Fruergaard's Final Earnings as CEO

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
+1+1
#2 Investment Sidebar Snapshots

#2 Investment Sidebar Snapshots

Compiling One Month of Novo Nordisk News & Updates

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
+1+1
Novo Nordisk - H1 2025 Earnings Review

Novo Nordisk - H1 2025 Earnings Review

When Expectations Are So Low...

The Octopus Value Investing
The Octopus Value Investing
Novo NordiskNovo Nordisk
Novo Nordisk Valuation Update

Novo Nordisk Valuation Update

The Margin of Safety Might Have Never Been Larger

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
+1+1
Novo Nordisk A/S - 2024 Earnings Review

Novo Nordisk A/S - 2024 Earnings Review

When Expectations Are So Low Tha

The Octopus Value Investing
The Octopus Value Investing
News & Trending TopicsNews & Trending Topics
+1+1
CagriSema Phase III Results Review

CagriSema Phase III Results Review

Novo Nordisk Stock Plunge: Overreaction or Justified?

The Octopus Value Investing
The Octopus Value Investing
PandoraPandora
+3+3
Q3 2024 Earnings Recap

Q3 2024 Earnings Recap

Earnings Review Compilation of Novo Nordisk, Pandora & Lonza AG

The Octopus Value Investing
The Octopus Value Investing
News & Trending TopicsNews & Trending Topics
+1+1
Novo Nordisk September 2024 recap

Novo Nordisk September 2024 recap

An hectic month for the Danish company

The Octopus Value Investing
The Octopus Value Investing
MiscellaneousMiscellaneous
+1+1
Understanding NASH/MASH

Understanding NASH/MASH

Uncovering the potential behind Novo Nordisk's optionality

The Octopus Value Investing
The Octopus Value Investing
Earnings ReviewEarnings Review
+1+1
Novo Nordisk - H1 2024 Earnings review

Novo Nordisk - H1 2024 Earnings review

More leader in the GLP-1 space than ever

The Octopus Value Investing
The Octopus Value Investing
Novo NordiskNovo Nordisk
#3 The Octopus Toolbox - The Novo Nordisk Report

#3 The Octopus Toolbox - The Novo Nordisk Report

My podcast with MDBolsa in writing

The Octopus Value Investing
The Octopus Value Investing
News & Trending TopicsNews & Trending Topics
+2+2
Novo Nordisk - 2023 Earnings Review

Novo Nordisk - 2023 Earnings Review

The GLP-1 growth engine keeps working like a clockwork

The Octopus Value Investing
The Octopus Value Investing